Maria Cuevas

1.2k total citations
20 papers, 884 citations indexed

About

Maria Cuevas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Maria Cuevas has authored 20 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Maria Cuevas's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal and Anal Carcinomas (4 papers). Maria Cuevas is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal and Anal Carcinomas (4 papers). Maria Cuevas collaborates with scholars based in Argentina, United States and United Kingdom. Maria Cuevas's co-authors include M. Machiavelli, Carlos Vallejo, Chris Nugent, Paul Muschamp, Adrian Moore, Hanif Ullah, J. Eduardo Pérez, J. Lacava, A. Romero and Mario Rabinovich and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Maria Cuevas

20 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Cuevas Argentina 12 339 208 182 114 101 20 884
Álvaro Suárez Spain 11 180 0.5× 111 0.5× 159 0.9× 117 1.0× 50 0.5× 51 813
Christian Weiß Germany 25 457 1.3× 131 0.6× 63 0.3× 99 0.9× 323 3.2× 85 1.9k
Stefano Forti Italy 18 159 0.5× 207 1.0× 773 4.2× 64 0.6× 50 0.5× 68 1.3k
Sofiane Maza Germany 14 129 0.4× 59 0.3× 60 0.3× 54 0.5× 146 1.4× 32 601
Takeshi Sasaki Japan 19 194 0.6× 42 0.2× 20 0.1× 95 0.8× 68 0.7× 88 888
HyungJun Cho South Korea 25 596 1.8× 88 0.4× 56 0.3× 278 2.4× 438 4.3× 129 2.3k
Luca Melis Italy 19 189 0.6× 23 0.1× 63 0.3× 31 0.3× 128 1.3× 47 1.3k
Xingwu Zhu China 11 215 0.6× 31 0.1× 53 0.3× 154 1.4× 65 0.6× 17 651
Rikiya Abe Japan 18 528 1.6× 307 1.5× 33 0.2× 271 2.4× 130 1.3× 122 1.3k
Mitsuhiro Kubota Japan 16 203 0.6× 164 0.8× 154 0.8× 105 0.9× 341 3.4× 60 897

Countries citing papers authored by Maria Cuevas

Since Specialization
Citations

This map shows the geographic impact of Maria Cuevas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Cuevas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Cuevas more than expected).

Fields of papers citing papers by Maria Cuevas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Cuevas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Cuevas. The network helps show where Maria Cuevas may publish in the future.

Co-authorship network of co-authors of Maria Cuevas

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Cuevas. A scholar is included among the top collaborators of Maria Cuevas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Cuevas. Maria Cuevas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Condoluci, Massimo, et al.. (2019). Fixed-Mobile Convergence in the 5G Era: From Hybrid Access to Converged Core. IEEE Network. 33(2). 138–145. 21 indexed citations
2.
Ullah, Hanif, et al.. (2019). 5G Communication: An Overview of Vehicle-to-Everything, Drones, and Healthcare Use-Cases. IEEE Access. 7. 37251–37268. 225 indexed citations
3.
Lema, María A., Andrés Laya, Toktam Mahmoodi, et al.. (2017). Business Case and Technology Analysis for 5G Low Latency Applications. IEEE Access. 1–1. 146 indexed citations
4.
Cuevas, Maria, et al.. (2008). In vitro cytotoxic activity of anthrapyrazole analogues in human prostate DU-145 and testicular NTERA-2 carcinoma cells. Oncology Reports. 20(1). 239–44. 2 indexed citations
5.
Cuevas, Maria. (2005). Admission control and resource reservation for session-based applications in next generation networks. BT Technology Journal. 23(2). 130–145. 6 indexed citations
6.
Fernández, Cristina, et al.. (2004). Acute urticaria induced by hyoscine butylbromide. Allergy. 59(7). 787–788. 14 indexed citations
7.
Romero, Alberto, J. Eduardo Pérez, Maria Cuevas, et al.. (1998). Double Modulation of 5-Fluorouracil by Methotrexate and High-Dose L-Leucovorin in Advanced Colorectal Cancer. American Journal of Clinical Oncology. 21(1). 94–98. 3 indexed citations
8.
Lacava, J., B Leone, M. Machiavelli, et al.. (1997). Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.. Journal of Clinical Oncology. 15(2). 604–609. 48 indexed citations
9.
Paradiso, Angelo, Mario Rabinovich, Carlos Vallejo, et al.. (1996). p53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis. International Journal of Cancer. 69(6). 437–441. 50 indexed citations
10.
Vallejo, Carlos, J. Eduardo Pérez, Maria Cuevas, et al.. (1996). Ifosfamide and Cisplatin as Neoadjuvant Chemotherapy for Advanced Cervical Carcinoma. American Journal of Clinical Oncology. 19(2). 132–135. 39 indexed citations
11.
Leone, B, Carlos Vallejo, Alberto Romero, et al.. (1996). Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 14(11). 2993–2999. 22 indexed citations
12.
Vallejo, Carlos, A. Romero, J. Eduardo Pérez, et al.. (1996). Ifosfamide and Vinorelbine as First-Line Chemotherapy for Advanced Non-Small Cell Lung Carcinoma. American Journal of Clinical Oncology. 19(6). 584–588. 10 indexed citations
13.
Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1995). High-Dose Cisplatin with Dipyridamole in Advanced Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 18(3). 185–188. 6 indexed citations
14.
Romero, A., Mario Rabinovich, Carlos Vallejo, et al.. (1994). Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.. Journal of Clinical Oncology. 12(2). 336–341. 168 indexed citations
15.
Rodríguez, Rosario, M. Machiavelli, B Leone, et al.. (1994). Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia. Annals of Oncology. 5(8). 769–770. 48 indexed citations
16.
Lena, M. De, A. Romero, Mario Rabinovich, et al.. (1993). Metastatic Pattern and DNA Ploidy in Stage IV Breast Cancer at Initial Diagnosis. American Journal of Clinical Oncology. 16(3). 245–249. 6 indexed citations
17.
Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1993). Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 11(3). 461–466. 4 indexed citations
18.
Rabinovich, Mario, Carlos Vallejo, J. Eduardo Pérez, et al.. (1992). Development and Validation of Prognostic Models in Metastatic Breast Cancer: A GOCS Study. Oncology. 49(3). 188–195. 11 indexed citations
19.
Machiavelli, M., B Leone, A. Romero, et al.. (1991). Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.. PubMed. 14(3). 211–7. 11 indexed citations
20.
Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1990). Bone-Only Versus Visceral-Only Metastatic Pattern in Breast Cancer. American Journal of Clinical Oncology. 13(4). 294–298. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026